1.
Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab.
2.
3.
4.
5.
Laparoscopy to predict the result of primary cytoreductive surgery in advanced ovarian cancer patients (LapOvCa-trial): a multicentre randomized controlled study